Immune Defense Mixed Berry Flavor
Culturelle Immune Defense Mixed Berry Flavor is an immune support combination product featuring 6 ingredients. Each chewable tablet provides 90mg of Vitamin C, which is at a clinically studied dose, alongside 1.88mg of Zinc, which is underdosed compared to typical clinical recommendations for immune support. It also includes 26mg of Lactobacillus rhamnosus GG and 50mg of Elderberry powder. This product received an N+ Score of 54, earning it an 'F' grade, indicating a below-average formulation primarily due to ingredient adequacy and formula completeness concerns, despite good label transparency. Individuals seeking a multi-ingredient immune support chewable with some clinically dosed components might consider this product, though some key ingredients are underdosed.
About This Product
Immune Defense Mixed Berry Flavor by Culturelle is a probiotics supplement containing 6 active ingredients. It has earned an N+ Score of 54/100 (Grade F).
Notable clinical-dose ingredients include Vitamin C.
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Fully transparent label with individual ingredient amounts disclosed
- +Broad ingredient diversity exceeding category norms
- +1 ingredient(s) at clinical dose levels
Weaknesses
- −Several ingredients below clinically effective doses
- −Missing several expected ingredients for its category
Ingredient Analysis (6 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Calories | — | N/A |
| Vitamin C | 90.000 mg | Adequate |
| Zinc | 1.880 mg | Under |
| Total Carbohydrates | 1.000 Gram(s) | N/A |
| Elderberry, Powder | 50.000 mg | N/A |
| Lactobacillus rhamnosus GG | 26.000 mg | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.